Literature DB >> 33202142

Vitamin D Deficiency Is Associated with Increased Nontuberculous Mycobacteria Risk in Cystic Fibrosis.

William J Richter1, Yuqing Sun1, Kevin J Psoter1, Matthew N Santos1, Jan A Nguyen1, Aniket Sidhaye1, Noah Lechtzin1, Mark T Jennings1, Keira A Cohen1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33202142      PMCID： PMC8086535          DOI： 10.1513/AnnalsATS.202003-216RL

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  11 in total

1.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

2.  Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.

Authors:  Jennifer Adjemian; Kenneth N Olivier; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2014-09-01       Impact factor: 21.405

3.  Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF).

Authors:  Laura Viviani; Michael J Harrison; Anna Zolin; Charles S Haworth; R Andres Floto
Journal:  J Cyst Fibros       Date:  2016-04-01       Impact factor: 5.482

4.  An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation.

Authors:  V Tangpricha; A Kelly; A Stephenson; K Maguiness; J Enders; K A Robinson; B C Marshall; D Borowitz
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

5.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors:  Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

6.  Severe vitamin D deficiency is associated with non-tuberculous mycobacterial lung disease: a case-control study.

Authors:  Kyeongman Jeon; Su-Young Kim; Byeong-Ho Jeong; Boksoon Chang; Sung Jae Shin; Won-Jung Koh
Journal:  Respirology       Date:  2013-08       Impact factor: 6.424

7.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study.

Authors:  R J Wilkinson; M Llewelyn; Z Toossi; P Patel; G Pasvol; A Lalvani; D Wright; M Latif; R N Davidson
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

8.  Vitamin d deficiency in cystic fibrosis.

Authors:  William B Hall; Amy A Sparks; Robert M Aris
Journal:  Int J Endocrinol       Date:  2010-01-28       Impact factor: 3.257

9.  The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.

Authors:  Emily A Knapp; Aliza K Fink; Christopher H Goss; Ase Sewall; Josh Ostrenga; Christopher Dowd; Alexander Elbert; Kristofer M Petren; Bruce C Marshall
Journal:  Ann Am Thorac Soc       Date:  2016-07

10.  US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.

Authors:  R Andres Floto; Kenneth N Olivier; Lisa Saiman; Charles L Daley; Jean-Louis Herrmann; Jerry A Nick; Peadar G Noone; Diana Bilton; Paul Corris; Ronald L Gibson; Sarah E Hempstead; Karsten Koetz; Kathryn A Sabadosa; Isabelle Sermet-Gaudelus; Alan R Smyth; Jakko van Ingen; Richard J Wallace; Kevin L Winthrop; Bruce C Marshall; Charles S Haworth
Journal:  Thorax       Date:  2016-01       Impact factor: 9.139
View more
  1 in total

Review 1.  Ancillary treatment of patients with lung disease due to non-tuberculous mycobacteria: a narrative review.

Authors:  Artmis Youssefnia; Alicia Pierre; Jeffrey M Hoder; Michelle MacDonald; Monica J B Shaffer; Jessica Friedman; Philip S Mehler; Amanda Bontempo; Francisco C N da Silva; Edward D Chan
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.